Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04497012
Other study ID # Pro00041470
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date November 17, 2020
Est. completion date July 31, 2025

Study information

Verified date June 2023
Source University of South Florida
Contact Marcia Kneusel
Phone 813-844-3395
Email mkneusel@usf.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized double-blinded study of enteral iron supplementation in Very Low Birth Weight infants. The subjects will be randomized into low dose (2 mg/kg/day) and high dose (6 mg/kg/day) of daily iron supplementation. The primary outcomes are intestinal health including microbiome, inflammation, and barrier function.


Description:

Infants and mothers will be recruited at a single academic level III NICU at Tampa General Hospital, Tampa, FL. Inclusion criteria infants: <1500 g at birth, expected to live beyond 2 weeks, not yet started on oral iron supplementation (OIS), and parental consent. Exclusion criteria infants: congenital intestinal defects, history of intestinal infection or perforation before OIS. Infants who require epogen for religious reason to prevent them from getting blood transfusions will be excluded from the study. Intervention: Participants will be randomized to either 6 mg/kg/day or 2 mg/kg/day total of elemental iron once a day when they are consuming 150-160 ml/kg/day of enteral feeds and are at least 14 days old. The total iron doses will be provided by fortification of feeds and liquid iron sulfate and will be weight adjusted once a week. The participants will receive the study OIS doses until 36 week corrected gestational age or discharge, whichever comes first. Sample collection and testing: 1. Stool and urine collection: We will collect weekly stool and urine samples non-invasively starting at enrollment until study completion. Samples will be collected from soiled diapers. 2. Blood tests: We will collect C-reactive protein (CRP) and ferritin level at 4 weeks after birth at the same time as other routine labs (complete blood count, reticulocyte count, and liver function test). 3. Monaural auditory brainstem response (ABR): for each ear will be performed at 36 weeks corrected gestational age or at discharge under the supervision of an audiologist who is blinded to the infants assigned iron doses and test results (stool microbiome, blood and urine tests). Monitoring: iron supplementation dose will be increased by 2 mg/kg/day if ferritin level <100 mg/dL and the dose will be held if ferritin level >400 mg/dL. Ferritin level will be rechecked every 2 weeks until normalized. Hematocrit and reticulocyte count will be monitored by the medical team.


Recruitment information / eligibility

Status Recruiting
Enrollment 183
Est. completion date July 31, 2025
Est. primary completion date November 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Day to 6 Months
Eligibility Inclusion Criteria: - <1500 g at birth, expected to live beyond 2 weeks, not yet started on oral iron supplementation (OIS), with mother at least 18 years of age, and parental consent. Exclusion Criteria: - congenital intestinal defects, history of intestinal infection or perforation before OIS. Infants who require epogen for religious reason to prevent them from getting blood transfusions will be excluded from the study.

Study Design


Intervention

Drug:
2mg/kg/day Iron Sulfate
Iron Sulfate will be given in liquid form via nasal or oral gastric tube with feeds.
6 mg/kg/day Iron Sulfate
Iron Sulfate will be given in liquid form via nasal or oral gastric tube with feeds.

Locations

Country Name City State
United States Tampa General Hospital Tampa Florida

Sponsors (2)

Lead Sponsor Collaborator
University of South Florida National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

References & Publications (6)

Jaeggi T, Kortman GA, Moretti D, Chassard C, Holding P, Dostal A, Boekhorst J, Timmerman HM, Swinkels DW, Tjalsma H, Njenga J, Mwangi A, Kvalsvig J, Lacroix C, Zimmermann MB. Iron fortification adversely affects the gut microbiome, increases pathogen abun — View Citation

Krebs NF, Sherlock LG, Westcott J, Culbertson D, Hambidge KM, Feazel LM, Robertson CE, Frank DN. Effects of different complementary feeding regimens on iron status and enteric microbiota in breastfed infants. J Pediatr. 2013 Aug;163(2):416-23. doi: 10.101 — View Citation

Mills RJ, Davies MW. Enteral iron supplementation in preterm and low birth weight infants. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD005095. doi: 10.1002/14651858.CD005095.pub2. — View Citation

Strauss RG. Anaemia of prematurity: pathophysiology and treatment. Blood Rev. 2010 Nov;24(6):221-5. doi: 10.1016/j.blre.2010.08.001. — View Citation

Tang M, Frank DN, Hendricks AE, Ir D, Esamai F, Liechty E, Hambidge KM, Krebs NF. Iron in Micronutrient Powder Promotes an Unfavorable Gut Microbiota in Kenyan Infants. Nutrients. 2017 Jul 19;9(7):776. doi: 10.3390/nu9070776. — View Citation

Zimmermann MB, Chassard C, Rohner F, N'goran EK, Nindjin C, Dostal A, Utzinger J, Ghattas H, Lacroix C, Hurrell RF. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in stool bacterial percentages from before to after iron supplementation Comparing the changes in the median percentages of stool bacteria between the two groups. Change = post-iron (1 week, 2 weeks after iron and at discharge) - pre-iron from baseline to 1 week and 2 weeks after iron supplementation started
Primary Change in fecal calprotectin from before to after iron supplementation Comparing the mean fecal calprotectin levels, an inflammatory stool biomarker, between the two groups. Change = post-iron (1 week, 2 weeks after iron and at discharge) - pre-iron. from baseline to 1 week and 2 weeks after iron supplementation started
Primary Change in urine Claudin-3 and I-FABP from before to after iron supplementation Comparing the mean urine claudin-3 and I-FABP levels, biomarkers for intestinal barrier function, between the two groups. Change = post-iron (1 week, 2 weeks after iron and at discharge) - pre-iron from baseline to 1 week and 2 weeks after iron supplementation started
Secondary Rate of auditory myelination Comparing the mean auditory latency levels between the two groups at 36 weeks corrected gestational age or at discharge. up to 36 weeks corrected gestational age
Secondary Level of Iron storage Comparing the mean Ferritin levels between the two groups at 4 weeks after birth at 4 weeks after birth
See also
  Status Clinical Trial Phase
Recruiting NCT04542096 - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Not yet recruiting NCT04041765 - IgM-Enriched Immunoglobulin for Neonatal Sepsis Phase 3
Completed NCT01683760 - Pharmacokinetic Study of Fluconazole in Premature Infants Phase 2
Completed NCT04282655 - Effect of Milk Warming on the Very Low Birth Weight Infant N/A
Active, not recruiting NCT05436925 - CGM Use in Preterm Infants
Completed NCT01515696 - Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants Phase 4
Recruiting NCT05308134 - Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM) N/A
Completed NCT03682575 - Work of Breathing in Premature Infants at Discharge
Terminated NCT02987764 - Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants N/A
Completed NCT05686252 - RCT: The Effect of Held Position During Kangaroo Care on Physiological Parameters of Premature Infants N/A
Not yet recruiting NCT05806684 - Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
Completed NCT03916159 - Extrauterine Placental Transfusion In Neonatal Resuscitation Of Very Low Birth Weight Infants N/A
Not yet recruiting NCT04640805 - Targeted Fortification of Pasteurized Donor Human Milk N/A
Completed NCT06200324 - Clinical Outcomes of Ready-to-Use Parenteral Nutrition in Low Birth Weight Newborns in Colombia 2017-2023
Completed NCT05022433 - Comparison of the Shukla and UN-1 Formulae in the Placement of the Umbilical Venous Catheter Among Neonates
Not yet recruiting NCT03163212 - Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants Early Phase 1
Completed NCT00962754 - Fluid Balance Study in Sick Neonates Phase 4
Not yet recruiting NCT06433674 - Enteral Zinc Supplementation in Very Low Birth Weight Infants Phase 3
Recruiting NCT05961657 - USCOM Parameters in Preterm Infants: Reference Ranges
Completed NCT05406804 - Olfactory Stimulation for Very Low Birth Weight Infants N/A